Live Case Procedure to Demonstrate Capabilities of Novel Coronary Imaging System
|
By HospiMedica International staff writers Posted on 04 Mar 2010 |
|
An innovative coronary imaging system utilizes catheter-based near-infrared (NIR) spectroscopy to identify and evaluate the composition of intracoronary plaques within artery walls that cannot be detected by typically used diagnostic tests such as treadmill exams and coronary angiograms.
InfraReDx, Inc. (Burlington, MA, USA), a medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased tissues, announced that its commercially available LipiScan coronary imaging system was featured at the Scottsdale Interventional Forum (AZ, USA), an international conference for Interventional Cardiologists and other healthcare professionals. The Forum was held February 11-13, 2010 in conjunction with the Scottsdale Healthcare Shea Medical Center. David G. Rizik, M.D., Scottsdale Healthcare medical director of invasive cardiology, will performed "live case” demonstrations of the LipiScan system, February 11 and 12, 2010.
InfraReDx's LipiScan system is the only U.S. Food and Drug Administration (FDA)-cleared product to detect lipid core plaque. "The ability to detect vulnerable coronary and fatty plaques using the LipiScan technology is of great interest to the Interventional cardiology community and it represents an important advance in patient care,” said Dr. Rizik. "With the information provided by LipiScan on the chemical makeup of coronary artery plaques, which I look forward to demonstrating via the live case broadcasts, our practice is better equipped to identify the coronary plaques of particular concern--those with lipid cores. As a result of this improved imaging and robust diagnostic capability, we are better prepared to characterize patients' plaques, reduce stenting complications, and ultimately determine the most appropriate treatment for patients with coronary artery disease.”
Lipid core-containing plaque is believed to be vulnerable plaque, or fatty plaque that can rupture and form dangerous blood clots. Vulnerable coronary artery plaque is widely considered the primary cause of acute coronary events (sudden cardiac deaths, strokes, non-fatal heart attacks), the leading cause of death in the developed world. The LipiScan system has been used in more than 800 patients at approximately 20 cardiovascular healthcare centers in the United States.
"We are very pleased that Dr. Rizik and Scottsdale Healthcare are successfully utilizing our near infrared LipiScan system, and demonstrating its unique capabilities at this key educational Forum,” stated James E. Muller, M.D., founder and chief executive officer of InfraReDx. "We are proud of this technology and the benefits it currently offers the Interventional cardiology community.”
InfraReDx is a medical device company focused on intravascular characterization of disease in the coronary arteries. InfraReDx is the maker of the LipiScan system, an NIR spectroscopy catheter that can detect the lipid core coronary plaques suspected to cause most heart attacks and known to complicate stenting procedures.
The annual Scottsdale Interventional Forum provides comprehensive knowledge of the leading trends and best practices in cardiovascular disease therapies for cardiologists, industry professionals, nurses, technologists, and other health professionals with specific interest in interventional cardiology.
Related Links:
InfraReDx
InfraReDx, Inc. (Burlington, MA, USA), a medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased tissues, announced that its commercially available LipiScan coronary imaging system was featured at the Scottsdale Interventional Forum (AZ, USA), an international conference for Interventional Cardiologists and other healthcare professionals. The Forum was held February 11-13, 2010 in conjunction with the Scottsdale Healthcare Shea Medical Center. David G. Rizik, M.D., Scottsdale Healthcare medical director of invasive cardiology, will performed "live case” demonstrations of the LipiScan system, February 11 and 12, 2010.
InfraReDx's LipiScan system is the only U.S. Food and Drug Administration (FDA)-cleared product to detect lipid core plaque. "The ability to detect vulnerable coronary and fatty plaques using the LipiScan technology is of great interest to the Interventional cardiology community and it represents an important advance in patient care,” said Dr. Rizik. "With the information provided by LipiScan on the chemical makeup of coronary artery plaques, which I look forward to demonstrating via the live case broadcasts, our practice is better equipped to identify the coronary plaques of particular concern--those with lipid cores. As a result of this improved imaging and robust diagnostic capability, we are better prepared to characterize patients' plaques, reduce stenting complications, and ultimately determine the most appropriate treatment for patients with coronary artery disease.”
Lipid core-containing plaque is believed to be vulnerable plaque, or fatty plaque that can rupture and form dangerous blood clots. Vulnerable coronary artery plaque is widely considered the primary cause of acute coronary events (sudden cardiac deaths, strokes, non-fatal heart attacks), the leading cause of death in the developed world. The LipiScan system has been used in more than 800 patients at approximately 20 cardiovascular healthcare centers in the United States.
"We are very pleased that Dr. Rizik and Scottsdale Healthcare are successfully utilizing our near infrared LipiScan system, and demonstrating its unique capabilities at this key educational Forum,” stated James E. Muller, M.D., founder and chief executive officer of InfraReDx. "We are proud of this technology and the benefits it currently offers the Interventional cardiology community.”
InfraReDx is a medical device company focused on intravascular characterization of disease in the coronary arteries. InfraReDx is the maker of the LipiScan system, an NIR spectroscopy catheter that can detect the lipid core coronary plaques suspected to cause most heart attacks and known to complicate stenting procedures.
The annual Scottsdale Interventional Forum provides comprehensive knowledge of the leading trends and best practices in cardiovascular disease therapies for cardiologists, industry professionals, nurses, technologists, and other health professionals with specific interest in interventional cardiology.
Related Links:
InfraReDx
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Patient Preoperative Skin Preparation
BD ChloraPrep
Syringe Pump
SP50 Series
Latest Critical Care News
- Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
- Bedside CSF Monitor Detects Early Infection in Fluid Drains
- Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
- New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
- AI ECG Tool Detects Cardiac Amyloidosis for Early Screening
- Cuffless Wearable Enables Continuous Blood Pressure Monitoring for Hypertension Care
- AI-Guided System Supports Cardiac Ultrasound Training on Cart-Based Systems
- AI ECG Index Tracks Pubertal Maturation in Children and Adolescents
- Noninvasive AI Tool Enables Pressure-Guided Heart Failure Management
- Regenerative Therapies Aim to Support Recovery After Traumatic Brain Injury
- Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines
- “Intelligent Tattoo” Method Detects Early Melanoma Signals
- Implantable Wireless Light Device Advances Bladder Cancer Treatment
- Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read more
Critical Care
view channel
Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
Atrial fibrillation, an irregular and often rapid heart rhythm, is the most common arrhythmia in adults. Elective electrical cardioversion is frequently canceled on the day of treatment when patients revert... Read more
New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
Benign prostatic hyperplasia is a noncancerous enlargement of the prostate that can cause lower urinary tract symptoms and impair daily functioning. These symptoms erode sleep, productivity, and sexual... Read more
Bedside CSF Monitor Detects Early Infection in Fluid Drains
External drainage of cerebrospinal fluid (CSF) after traumatic brain injury, hydrocephalus, or hemorrhage carries a significant risk of infection. These infections can prolong intensive care, cause severe... Read more
Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
Cardiac arrhythmias, including slow and irregular heart rhythms, often require pacemakers that are surgically implanted. While effective, implants carry procedural risks and long-term device maintenance burdens.... Read moreSurgical Techniques
view channel
CE-Marked Ultrasonic Shears Streamline Breast and Thyroid Surgery
Thyroid and breast surgeries are often performed in confined anatomical spaces near critical structures, making precise dissection and controlled thermal management essential. As the global disease burden... Read more
3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
Tetralogy of Fallot is one of the most common congenital heart problems and often requires surgery in infancy. Many survivors later develop conduction abnormalities because the cardiac electrical system... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
Point of Care
view channel
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read more
Business
view channel
Endologix Adds FDA-Cleared Peripheral Thrombectomy System
Endologix (Santa Rosa, CA, USA) has acquired the Pounce Thrombectomy System from Surmodics, with the transaction closing on May 18, 2026. The FDA-cleared system is indicated for the non-surgical removal... Read more
